LRG Staff

Home/LRG Staff

About LRG Staff

This author has not yet filled in any details.
So far LRG Staff has created 517 blog entries.

LRG Webcast Series: Finding Biomarkers that Cause GIST: From Research to Clinical Application

Dr. Lori Rink, Fox Chase Cancer Center, and Dr. Inga-Marie Schaefer, Brigham & Women’s Hospital, are two researchers who are making discoveries in their respective laboratories to uncover the unique biomarkers in GIST that will be future drug targets.

By |2021-03-02T08:14:24-05:00March 2nd, 2021|News, Webcast|

GIST Expert Dr. Jason Sicklick & Team Release New Study on What Drives GIST

In a recent study, researchers at University of California San Diego School of Medicine identified new therapeutic targets that could lead to new treatment options for patients. The study, published in the February 18, 2021 online edition of Oncogene, found that specific cell-to-cell communication influences GIST biology and is strongly associated with cancer progression and metastasis.

By |2021-02-19T08:58:23-05:00February 19th, 2021|GIST Education, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – MaKayla Evans Talks Testing

Understanding the role of mutations and biomarker testing is one of most important things patients must learn. Uncovering the driving force behind each individual’s tumors is not just important, it is critical. This video talks about why it's important.

By |2021-02-17T09:27:51-05:00February 17th, 2021|Mutational Testing, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – Resources List

Understanding the role of mutations and biomarker testing is one of most important things patients must learn. Uncovering the driving force behind each individual’s tumors is not just important, it is critical. Here is a Resource list for GIST and other cancers.

By |2021-02-09T08:17:24-05:00February 8th, 2021|Mutational Testing, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – LRG Patient Registry Video

Understanding the role of mutations and biomarker testing is one of most important things patients must learn. Uncovering the driving force behind each individual’s tumors is not just important, it is critical. This video talks about why it's important.

By |2021-02-08T11:47:40-05:00February 8th, 2021|Mutational Testing, News|

NCCN Shares New Guidance Principles for Vaccinating People with Cancer Against COVID-19

NCCN repost - Leading cancer and infectious disease experts offer preliminary advice on how to quickly, safely, and efficiently protect vulnerable patients from COVID-19; with more updates to come.

By |2021-01-27T14:24:30-05:00January 27th, 2021|News, Patient Support|
Go to Top